Medicare Enrolled
Dr. Sunny Philip, M.D.
Hematology & Oncology · Lodi, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Philip from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Philip?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Philip
Dr. Sunny Philip is a hematology & oncology specialist in Lodi, CA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Philip performed 123,262 Medicare services across 2,194 unique beneficiaries.
Between the years covered by Open Payments, Dr. Philip received a total of $22,405 from 94 pharmaceutical and/or device companies across 802 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Philip is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 5% volume in CA
$22,405 industry payments
Medicare Practice Summary
Medicare Utilization ↗123,262
Medicare services
Top 5% in CA for hematology & oncology
2,194
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~8,217 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
71,250 | $1 | $33 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
13,800 | $0 | $18 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
13,260 | $0 | $15 |
| Denosumab injection (Prolia/Xgeva) | 8,580 | $18 | $69 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,706 | $0 | $17 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
2,340 | $6 | $42 |
| Injection, leucovorin calcium, per 50 mg | 1,782 | $3 | $37 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,680 | $1 | $28 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
1,028 | $2 | $35 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
668 | $101 | $384 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
598 | $12 | $46 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
569 | $113 | $417 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
465 | $70 | $270 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
460 | $13 | $52 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
442 | $25 | $91 |
| Flow cytometry, additional marker An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis. |
415 | $21 | $73 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
277 | $62 | $228 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
262 | $53 | $202 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
240 | $24 | $91 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
229 | $1 | $31 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
217 | $8 | $36 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
151 | $139 | $544 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
147 | $54 | $201 |
| New patient office visit, complex (60-74 min) | 141 | $169 | $660 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
133 | $11 | $41 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
132 | $17 | $64 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
128 | $144 | $473 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
121 | $17 | $64 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 114 | $131 | $547 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
89 | $28 | $106 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
89 | $19 | $83 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
87 | $141 | $533 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
76 | $8 | $24 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 74 | $341 | $1,476 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 64 | $282 | $1,043 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
58 | $1,382 | $4,927 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
49 | $1 | $30 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
48 | $27 | $117 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
48 | $2 | $37 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
46 | $65 | $239 |
| Injection, hydrocortisone sodium succinate, up to 100 mg | 44 | $14 | $54 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
44 | $1 | $34 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
43 | $97 | $361 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
36 | $136 | $470 |
| Flow cytometry DNA or cell analysis, first marker A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell. |
19 | $65 | $230 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
13 | $224 | $552 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
70.0% high complexity
27.7% medium
2.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$22,405
Total received (2018-2024)
Avg $3,201/year across 7 years
Top 19% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
94
Companies
802
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,054 (71.7%)
Other
Charitable contributions, space rental, and other categories
$3,019 (13.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,016 (9.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,316 (5.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,120
2023
$3,837
2022
$3,662
2021
$3,205
2020
$2,365
2019
$2,326
2018
$1,890
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,316
Novartis Pharmaceuticals Corporation
$1,243
E.R. Squibb & Sons, L.L.C.
$210
Tempus AI, Inc
$169
PFIZER INC.
$169
Janssen Biotech, Inc.
$158
Lilly USA, LLC
$139
Celgene Corporation
$122
Merck Sharp & Dohme LLC
$114
Astellas Pharma US Inc
$109
Daiichi Sankyo Inc.
$106
Takeda Pharmaceuticals U.S.A., Inc.
$97
ABBVIE INC.
$87
Ipsen Biopharmaceuticals, Inc
$86
Coherus Biosciences Inc.
$86
Genentech USA, Inc.
$85
BeiGene USA, Inc.
$57
ARRAY BIOPHARMA INC
$55
Incyte Corporation
$52
Pharmacosmos Therapeutics Inc.
$44
TerSera Therapeutics LLC
$44
Agios Pharmaceuticals, Inc.
$41
Bayer Healthcare Pharmaceuticals Inc.
$38
Amgen Inc.
$34
Immunocore Limited
$33
Myriad Genetic Laboratories, Inc.
$31
Eisai Inc.
$30
Alexion Pharmaceuticals, Inc.
$29
SpringWorks Therapeutics, Inc.
$28
Novocure Inc.
$28
Regeneron Healthcare Solutions, Inc.
$27
Deciphera Pharmaceuticals Inc.
$26
ACCORD HEALTHCARE, INC.
$25
Kyowa Kirin, Inc.
$24
SERVIER PHARMACEUTICALS LLC
$22
Alnylam Pharmaceuticals Inc.
$22
SOBI, INC
$21
Aveo Pharmaceuticals, Inc.
$21
Genmab U.S., Inc.
$20
Gilead Sciences, Inc.
$20
Apellis Pharmaceuticals, Inc.
$19
Mirati Therapeutics, Inc.
$17
Azurity Pharmaceuticals, Inc.
$15
Top 3 companies account for 54.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$3,122
AstraZeneca Pharmaceuticals LP
$1,904
Rigel Pharmaceuticals, Inc.
$1,682
NOVARTIS PHARMACEUTICALS CORPORATION
$1,456
PFIZER INC.
$1,037
E.R. Squibb & Sons, L.L.C.
$904
Janssen Biotech, Inc.
$844
Amgen Inc.
$808
Takeda Pharmaceuticals U.S.A., Inc.
$670
Celgene Corporation
$628
Genentech USA, Inc.
$561
GENZYME CORPORATION
$544
Astellas Pharma US Inc
$534
Daiichi Sankyo Inc.
$479
Lilly USA, LLC
$474
Kite Pharma, Inc.
$362
Gilead Sciences, Inc.
$346
Merck Sharp & Dohme Corporation
$313
Merck Sharp & Dohme LLC
$290
Incyte Corporation
$283
Clovis Oncology, Inc.
$264
ARRAY BIOPHARMA INC
$214
Blueprint Medicines Corporation
$183
Tempus AI, Inc
$169
Stemline Therapeutics Inc.
$165
Acrotech Biopharma LLC
$164
AbbVie, Inc.
$153
Regeneron Healthcare Solutions, Inc.
$150
Monteris Medical Corporation
$140
SOBI, INC
$138
Seagen Inc.
$135
ABBVIE INC.
$133
BeiGene USA, Inc.
$132
Coherus Biosciences Inc.
$127
Octapharma USA, Inc.
$111
Pharmacyclics LLC, An AbbVie Company
$111
MorphoSys, US Inc.
$106
TerSera Therapeutics LLC
$103
SERVIER PHARMACEUTICALS LLC
$99
Janssen Scientific Affairs, LLC
$95
Sobi, Inc
$92
Exelixis Inc.
$89
Novocure Inc.
$88
Eisai Inc.
$88
Ipsen Biopharmaceuticals, Inc
$86
Agios Pharmaceuticals, Inc.
$85
Bayer HealthCare Pharmaceuticals Inc.
$83
Deciphera Pharmaceuticals Inc.
$77
Karyopharm Therapeutics Inc.
$74
Puma Biotechnology, Inc.
$73
Mirati Therapeutics, Inc.
$59
EMD Serono, Inc.
$58
Epizyme, Inc.,
$57
Bayer Healthcare Pharmaceuticals Inc.
$56
GlaxoSmithKline, LLC.
$55
Acceleron Pharma, Inc.
$53
Boehringer Ingelheim Pharmaceuticals, Inc.
$53
Kyowa Kirin, Inc.
$52
Myovant Sciences Inc.
$52
Myriad Genetic Laboratories, Inc.
$51
Genmab U.S., Inc.
$50
PharmaEssentia USA Corporation
$48
Pharmacosmos Therapeutics Inc.
$44
Alnylam Pharmaceuticals Inc.
$40
Blue Earth Diagnostics Limited
$40
Shire North American Group Inc
$40
Helsinn Therapeutics (U.S.), Inc.
$39
Aurobindo Pharma USA, Inc.
$36
Immunocore Limited
$33
CTI BioPharma Corp.
$31
Pharmacyclics LLC, an AbbVie Company
$30
Alexion Pharmaceuticals, Inc.
$29
SpringWorks Therapeutics, Inc.
$28
EISAI INC.
$28
Verastem, Inc.
$25
ACCORD HEALTHCARE, INC.
$25
Aadi Bioscience, Inc.
$24
Foundation Medicine, Inc.
$23
G1 Therapeutics, Inc.
$22
TAIHO ONCOLOGY, INC.
$21
Aveo Pharmaceuticals, Inc.
$21
Array BioPharma Inc.
$20
Jazz Pharmaceuticals Inc.
$20
Apellis Pharmaceuticals, Inc.
$19
Janssen Pharmaceuticals, Inc
$19
Forte Bio-Pharma LLC
$19
Dendreon Pharmaceuticals LLC
$17
AMAG Pharmaceuticals, Inc.
$15
R-Pharm US LLC
$15
Azurity Pharmaceuticals, Inc.
$15
Telix Pharmaceuticals
$14
Lexicon Pharmaceuticals, Inc.
$14
Taiho Oncology, Inc.
$13
Seattle Genetics, Inc.
$13
Top 3 companies account for 29.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · Axumin · BELEODAQ · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Beleodaq · Braftovi · CALQUENCE · CAMCEVI · CARVYKTI · COSELA · CRESEMBA · CUTAQUIG · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · EVENITY · Empaveli · Enhertu · Epkinly · Erleada · FASLODEX · FERAHEME · FOLOTYN · FOTIVDA · FRUZAQLA · Fyarro · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · IBRANCE · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Ixempra · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MYRISK · NERLYNX · NINLARO · Nalocet · Nerlynx · Neulasta · Neuroblate · Nplate · Nubeqa · OBIZUR · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · OPDIVO · ORGOVYX · OXBRYTA · Oncology · Onivyde · Optune · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Phesgo · Polivy · Pomalyst · Poteligeo · PreciseTumor · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SPRYCEL · SUTENT · Stivarga · TABRECTA · TAGRISSO · TALVEY · TALZENNA · TASIGNA · TAZVERIK · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VIVIMUSTA · VONVENDI · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vonjo · Vyloy · XALKORI · XARELTO · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xospata · Xtandi · Yescarta · ZEJULA · ZYTIGA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (72%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
15
Per 100K population
1.9
County median income
$88,531
Nearest hospital
ST JOSEPH'S MEDICAL CENTER OF STOCKTON
11.8 mi
11.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Philip is a mixed practice specialist, with above-average Medicare volume (top 5% in CA), with low-engagement industry engagement in the top 19% of CA peers, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Philip experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Philip performed 71,250 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Philip receive payments from pharmaceutical companies?
Yes. Dr. Philip received a total of $22,405 from 94 companies across 802 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Philip's costs compare to other hematology & oncology specialists in Lodi?
Dr. Philip's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Philip) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Lodi
Browse hematology & oncology specialists in Lodi ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Rigel Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Rigel Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology